Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Short %
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Lim...  from the 2-10-06 PR

http://www.ptsc.com/news/press_releases/20060210.asp

  • To facilitate the conversion of the debentures, agreements between the Company and Lincoln and Swartz which prohibit each of Lincoln and Swartz from owning more than 4.99% of the Company's Common Stock will be amended to allow them to own up to 9.99% of the Common Stock. With their holdings exceeding 5% they will need to make appropriate SEC filings upon future dispositions of the Company's stock.

    • I guess I want to know if this is a correct statement or not?

    Thanks

    Reply New Message
    Prev Message Back To Forum Threaded View Next Message
    Share
    Share
    New Message
    Please login to post a reply